,,Rescue“-Indikation für Glykoprotein-IIb/IIIa-Rezeptor-Inhibition im Rahmen perkutaner Koronarintervention?

Author： Herrmann J. Haude M. Volbracht L. Altmann C. von Birgelen C. Eggebrecht H. Malyar N. Baumgart D. Mann K. Erbel R.

Publisher： Springer Publishing Company

ISSN： 0175-3851

Source： Intensivmedizin und Notfallmedizin, Vol.39, Iss.6, 2002-09, pp. : 520-528

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Routinemäßige angiographische Kontrolle nach perkutaner Koronarintervention: Eine sinnvolle Maßnahme im klinischen Alltag?

By Lauer Frank

Medizinische Klinik, Vol. 99, Iss. 5, 2004-05 ,pp. : 217-222

Springer Publishing Company

Access to resources Recommend Favorite

Combination pharmacotherapy with reduced-dose fibrinolytic and platelet GP IIb/IIIa inhibition

By Bush H.S.

Journal of Emergency Medicine, Vol. 25, Iss. 4, 2003-11 ,pp. : 421-426

Elsevier

Access to resources Recommend Favorite

A randomized trial assessing the impact of three different glycoprotein IIb/IIIa antagonists on glycoprotein IIb/IIIa platelet receptor inhibition and clinical endpoints in patients with acute coronary syndromes

CARDIOVASCULAR THERAPEUTICS (ELECTRONIC), Vol. 34, Iss. 5, 2016-10 ,pp. : 330-336

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of Glycoprotein IIb/IIIa Receptor Inhibition with Tirofiban on Minor Myocardial Damage in Angiographically Successful Percutaneous Coronary Angioplasty

Cardiology, Vol. 102, Iss. 1, 2004-04 ,pp. : 18-23

Karger

Access to resources Recommend Favorite

Glycoprotein IIb/IIIa Receptor Inhibition with Abciximab during Percutaneous Coronary Interventions Increases the Risk of Bleeding in Patients with Impaired Renal Function

Cardiology, Vol. 111, Iss. 4, 2008-04 ,pp. : 247-253

Karger

Access to resources Recommend Favorite